{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:41:24Z","timestamp":1770061284389,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120Z942"],"award-info":[{"award-number":["120Z942"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120Z942"],"award-info":[{"award-number":["120Z942"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120Z942"],"award-info":[{"award-number":["120Z942"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["120Z942"],"award-info":[{"award-number":["120Z942"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["22401106"],"award-info":[{"award-number":["22401106"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["22401106"],"award-info":[{"award-number":["22401106"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["22401106"],"award-info":[{"award-number":["22401106"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["22401106"],"award-info":[{"award-number":["22401106"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Selcuk University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Colorectal cancer (CRC) is a significant global health concern, often challenging to treat effectively with conventional methods and burdened by adverse effects. Scorpion venoms offer a unique avenue for exploration, given their ability to disrupt the cell cycle, inhibit growth, and trigger apoptosis. This study delves into the impact of <jats:italic>Mesobuthus eupeus<\/jats:italic> (<jats:italic>M. eupeus<\/jats:italic>) scorpion venom on the proliferation and progression of colorectal cancer at the molecular level. The total protein concentration in the venom (607.5\u00a0\u00b5g\/mL) also emphasized the rich composition and potential for therapeutic applications. The study reveals that <jats:italic>M. eupeus<\/jats:italic> venom effectively reduced the proliferation of DLD-1 and HT-29 colorectal cancer cells in a dose-dependent manner with IC<jats:sub>50<\/jats:sub> values of 4.32 and 7.61\u00a0\u00b5g\/mL, respectively. The venom also impedes cell migration, diminishes colony formation, and triggers apoptosis in the cancer cells. The venom also induced early and late apoptosis in the two cancer cell lines. The human colorectal cancer and apoptotic pathways were clarified at the molecular level using pathway panels, which revealed that 16 genes involved in colorectal cancer increased while 23 decreased. In the HT-29 cell line, 57 genes increased, and 1 decreased following venom treatment. Besides, the mRNA expression of 19 genes involved in the apoptotic pathway was increased, while 22 were reduced in DLD-1 cells. This study underscores the potential of <jats:italic>M. eupeus<\/jats:italic> venom as a natural therapeutic approach in the quest for cancer treatments.<\/jats:p>","DOI":"10.1007\/s12032-025-02689-2","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:30:22Z","timestamp":1744644622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mesobuthus eupeus venom modulates colorectal carcinoma signaling pathways and induces apoptosis"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4453-6936","authenticated-orcid":false,"given":"Havva Nur","family":"Canak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0881-9793","authenticated-orcid":false,"given":"Kemal","family":"Bas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0396-3975","authenticated-orcid":false,"given":"Ersen Ayd\u0131n","family":"Ya\u011fmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4449-6103","authenticated-orcid":false,"given":"Serdar","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"2689_CR1","doi-asserted-by":"publisher","first-page":"107327482110387","DOI":"10.1177\/10732748211038735","volume":"28","author":"P Pi\u00f1a-S\u00e1nchez","year":"2021","unstructured":"Pi\u00f1a-S\u00e1nchez P, Ch\u00e1vez-Gonz\u00e1lez A, Ruiz-Tachiqu\u00edn M, Vadillo E, Monroy-Garc\u00eda A, Montesinos JJ, Grajales R, Guti\u00e9rrez de la Barrera M, Mayani H. Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective. Cancer Control. 2021;28:10732748211038736. https:\/\/doi.org\/10.1177\/10732748211038735.","journal-title":"Cancer Control"},{"key":"2689_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/s0140-6736(16)31012-1","volume":"388","author":"Collaborators GMaCoD,","year":"2016","unstructured":"Collaborators GMaCoD,. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459\u2013544. https:\/\/doi.org\/10.1016\/s0140-6736(16)31012-1.","journal-title":"Lancet"},{"key":"2689_CR3","doi-asserted-by":"publisher","first-page":"1907698","DOI":"10.1155\/2019\/1907698","volume":"2019","author":"J Da","year":"2019","unstructured":"Da J, Xu M, Wang Y, Li W, Lu M, Wang Z. Kaempferol promotes apoptosis while inhibiting cell proliferation via androgen-dependent pathway and suppressing vasculogenic mimicry and invasion in prostate cancer. Anal Cell Pathol. 2019;2019:1907698.","journal-title":"Anal Cell Pathol"},{"key":"2689_CR4","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA: Cancer J Clin"},{"key":"2689_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153897","volume":"96","author":"B Ansari","year":"2022","unstructured":"Ansari B, Aschner M, Hussain Y, Efferth T, Khan H. Suppression of colorectal carcinogenesis by naringin. Phytomedicine. 2022;96: 153897. https:\/\/doi.org\/10.1016\/j.phymed.2021.153897.","journal-title":"Phytomedicine"},{"key":"2689_CR6","doi-asserted-by":"publisher","first-page":"11941","DOI":"10.3390\/ijms222111941","volume":"22","author":"HH Hasbullah","year":"2021","unstructured":"Hasbullah HH, Musa M. Gene therapy targeting p53 and KRAS for colorectal cancer treatment: A myth or the way forward? Int J Mol Sci. 2021;22:11941.","journal-title":"Int J Mol Sci"},{"key":"2689_CR7","doi-asserted-by":"publisher","first-page":"7530794","DOI":"10.1155\/2023\/7530794","volume":"2023","author":"Q Li","year":"2023","unstructured":"Li Q, Lei X, Zhu J, Zhong Y, Yang J, Wang J, Tan H. Radiotherapy\/chemotherapy-immunotherapy for cancer management: from mechanisms to clinical implications. Oxid Med Cell Longev. 2023;2023:7530794. https:\/\/doi.org\/10.1155\/2023\/7530794.","journal-title":"Oxid Med Cell Longev"},{"key":"2689_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/pharmaceutics14061213","volume":"14","author":"N Krasteva","year":"2022","unstructured":"Krasteva N, Georgieva M. Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials. Pharmaceutics. 2022;14:1213. https:\/\/doi.org\/10.3390\/pharmaceutics14061213.","journal-title":"Pharmaceutics"},{"key":"2689_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ejmech.2017.12.039","volume":"144","author":"A Rejhov\u00e1","year":"2018","unstructured":"Rejhov\u00e1 A, Opattov\u00e1 A, \u010cumov\u00e1 A, Sl\u00edva D, Vodi\u010dka P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2018;144:582\u201394.","journal-title":"Eur J Med Chem"},{"key":"2689_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1590\/S1678-91992006000300004","volume":"12","author":"O Ozkan","year":"2006","unstructured":"Ozkan O, Adig\u00fczel S, Ates C, Bozyigit I, Filazi A. Optimization of antiscorpion venom production. J Venom Anim Toxins Incl Trop Dis. 2006;12:390\u20139.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"2689_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0041-0101(81)90044-1","volume":"19","author":"P Delori","year":"1981","unstructured":"Delori P, Van Rietschoten J, Rochat H. Scorpion venoms and neurotoxins: an immunological study. Toxicon. 1981;19:393\u2013407. https:\/\/doi.org\/10.1016\/0041-0101(81)90044-1.","journal-title":"Toxicon"},{"key":"2689_CR12","first-page":"97","volume":"65","author":"\u00d6 \u00d6zkan","year":"2008","unstructured":"\u00d6zkan \u00d6. Scorpion antivenom production. Turk Bull Hygiene Exp Biol. 2008;65:97\u2013108.","journal-title":"Turk Bull Hygiene Exp Biol"},{"key":"2689_CR13","first-page":"16","volume":"7","author":"AK Al-Asmari","year":"2016","unstructured":"Al-Asmari AK, Kunnathodi F, Al Saadon K, Idris MM. Elemental analysis of scorpion venoms. J Venom Res. 2016;7:16.","journal-title":"J Venom Res"},{"key":"2689_CR14","first-page":"116","volume":"6","author":"EA Ya\u011fmur","year":"2022","unstructured":"Ya\u011fmur EA, Sipahio\u011flu \u00d6, Y\u0131lmaz \u00d6, K\u0131l\u0131\u00e7 MS. An anomaly of pecten in Mesobuthus turcicus Kova\u0159\u00edk et al., 2022 (Scorpiones: Buthidae). Commagene J Biol. 2022;6:116\u20138.","journal-title":"Commagene J Biol"},{"key":"2689_CR15","first-page":"1","volume":"2011","author":"F Kova\u0159\u00edk","year":"2011","unstructured":"Kova\u0159\u00edk F, Ya\u011fmur EA, Fet V, Navidpour S. On two subspecies of Mesobuthus eupeus (CL Koch, 1839) in Turkey (Scorpiones: Buthidae). Euscorpius. 2011;2011:1\u201315.","journal-title":"Euscorpius"},{"key":"2689_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1636\/T06-20.1","volume":"35","author":"C-M Shi","year":"2007","unstructured":"Shi C-M, Huang Z-S, Wang L, He L-J, Hua Y-P, Leng L, Zhang D-X. Geographical distribution of two species of Mesobuthus (Scorpiones, Buthidae) in China: insights from systematic field surveys and predictive models. J Arachnol. 2007;35:215\u201326.","journal-title":"J Arachnol"},{"key":"2689_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10408363.2019.1670614","volume":"57","author":"E Hissong","year":"2020","unstructured":"Hissong E, Pittman ME. Colorectal carcinoma screening: Established methods and emerging technology. Crit Rev Clin Lab Sci. 2020;57:22\u201336.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2689_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12029-019-00272-3","volume":"51","author":"A Naeem","year":"2020","unstructured":"Naeem A, Tun AM, Guevara E. Molecular genetics and the role of molecularly targeted agents in metastatic colorectal carcinoma. J Gastrointest Cancer. 2020;51:387\u2013400.","journal-title":"J Gastrointest Cancer"},{"key":"2689_CR19","doi-asserted-by":"publisher","first-page":"205031212110343","DOI":"10.1177\/20503121211034366","volume":"9","author":"DT Debela","year":"2021","unstructured":"Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, Kitui SK, Manyazewal T. New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med. 2021;9:20503121211034370.","journal-title":"SAGE Open Med"},{"key":"2689_CR20","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","volume":"11","author":"KdCF Bordon","year":"2020","unstructured":"Bordon KdCF, Cologna CT, Fornari-Baldo EC, Pinheiro-J\u00fanior EL, Cerni FA, Amorim FG, Anjolette FAP, Cordeiro FA, Wiezel GA, Cardoso IA. From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery. Front Pharmacol. 2020;11:1132.","journal-title":"Front Pharmacol"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1678-9199-19-5","volume":"19","author":"N Oukkache","year":"2013","unstructured":"Oukkache N, Chgoury F, Lalaoui M, Cano AA, Ghalim N. Comparison between two methods of scorpion venom milking in Morocco. J Venom Anim Toxins Incl Trop Dis. 2013;19:1\u20135.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"2689_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1124\/mol.65.3.630","volume":"65","author":"H J\u00e4ger","year":"2004","unstructured":"J\u00e4ger H, Dreker T, Buck A, Giehl K, Gress T, Grissmer S. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol. 2004;65:630\u20138.","journal-title":"Mol Pharmacol"},{"key":"2689_CR23","first-page":"195","volume":"23","author":"M Maleki","year":"2020","unstructured":"Maleki M, Dounighi NM. Purification and characterization of a novel type of neurotoxic peptides from the venom of the Iranian scorpion Hemiscorpius lepturus. Iran J Basic Med Sci. 2020;23:195.","journal-title":"Iran J Basic Med Sci"},{"key":"2689_CR24","first-page":"139","volume":"7","author":"M Khoobdel","year":"2013","unstructured":"Khoobdel M, Zahraei-Salehi T, Nayeri-Fasaei B, Khosravi M, Omidian Z, Motedayen MH, Akbari A. Purification of the immunogenic fractions and determination of toxicity in Mesobuthus eupeus (Scorpionida: Buthidae) venom. J Arthropod Borne Dis. 2013;7:139.","journal-title":"J Arthropod Borne Dis"},{"key":"2689_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/15569543.2024.2344471","volume":"43","author":"MM Gerges","year":"2024","unstructured":"Gerges MM, Abdel-Rahman MA, Rahmy TR, Sharma PP, Mehana AE. Cytotoxic activity and mechanism of action of Smp43 scorpion peptide against colorectal cancer cell line HCT-116. Toxin Rev. 2024;43:370\u201383.","journal-title":"Toxin Rev"},{"key":"2689_CR26","first-page":"760","volume":"23","author":"M Valizade","year":"2020","unstructured":"Valizade M, Vanani AR, Rezaei M, Khorsandi LS, Zeidooni L, Mahdavinia M. Mesobuthus eupeus venom induced injury in the colorectal carcinoma cell line (HT29) through altering the mitochondria membrane stability. Iran J Basic Med Sci. 2020;23:760.","journal-title":"Iran J Basic Med Sci"},{"key":"2689_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10529-022-03254-x","volume":"44","author":"MS Gandomkari","year":"2022","unstructured":"Gandomkari MS, Ayat H, Ahadi AM. Recombinantly expressed MeICT, a new toxin from Mesobuthus eupeus scorpion, inhibits glioma cell proliferation and downregulates Annexin A2 and FOXM1 genes. Biotech Lett. 2022;44:703\u201312.","journal-title":"Biotech Lett"},{"key":"2689_CR28","doi-asserted-by":"crossref","unstructured":"Guicciardi ME, Gores GJ. The death receptor pathway. Essent Apoptos: Guide Basic Clin Res 2009;119\u2013150.","DOI":"10.1007\/978-1-60327-381-7_5"},{"key":"2689_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-135","volume":"9","author":"C Krakstad","year":"2010","unstructured":"Krakstad C, Chekenya M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer. 2010;9:1\u201314.","journal-title":"Mol Cancer"},{"key":"2689_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","volume":"27","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, N\u00fa\u00f1ez G, Inohara N. A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-\u03baB activation. EMBO J. 2008;27:373\u201383.","journal-title":"EMBO J"},{"key":"2689_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.34172\/apb.2023.047","volume":"13","author":"B Shademan","year":"2023","unstructured":"Shademan B, Karamad V, Nourazarian A, Masjedi S, Isazadeh A, Sogutlu F, Avc\u0131 CB. MicroRNAs as targets for cancer diagnosis: Interests and limitations. Adv Pharm Bull. 2023;13:435.","journal-title":"Adv Pharm Bull"},{"key":"2689_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers H. Wnt\/\u03b2-catenin signaling in development and disease. Cell. 2006;127:469\u201380.","journal-title":"Cell"},{"key":"2689_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008052","volume":"4","author":"P Polakis","year":"2012","unstructured":"Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4: a008052.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2689_CR34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-\u03baB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749\u201359.","journal-title":"Nat Rev Immunol"},{"key":"2689_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-\u03baB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21:11\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2689_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S1470-2045(09)70187-1","volume":"10","author":"SJ Klug","year":"2009","unstructured":"Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das B, Del Mistro A, Dybikowska A. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 2009;10:772\u201384.","journal-title":"Lancet Oncol"},{"key":"2689_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.27","volume":"2","author":"C Shi","year":"2022","unstructured":"Shi C, Liu X, Rahman JU, Liu G, Jiang Y. MicroRNA-144-3p controls the apoptosis of pulmonary artery endothelial cells in pulmonary arterial hypertension via the BMPR2\/Smad4 signaling pathway. Clin Transl Discov. 2022;2: e27.","journal-title":"Clin Transl Discov"},{"key":"2689_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.lungcan.2014.12.015","volume":"87","author":"H Yang","year":"2015","unstructured":"Yang H, Wang L, Zhao J, Chen Y, Lei Z, Liu X, Xia W, Guo L, Zhang H-T. TGF-\u03b2-activated SMAD3\/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer. Lung Cancer. 2015;87:249\u201357.","journal-title":"Lung Cancer"},{"key":"2689_CR39","volume":"2010","author":"S Jan\u010d\u00edk","year":"2010","unstructured":"Jan\u010d\u00edk S, Dr\u00e1bek J, Radzioch D, Hajd\u00fach M. Clinical relevance of KRAS in human cancers. Biomed Res Int. 2010;2010: 150960.","journal-title":"Biomed Res Int"},{"key":"2689_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.sjbs.2014.10.002","volume":"22","author":"MRM Hussain","year":"2015","unstructured":"Hussain MRM, Baig M, Mohamoud HSA, Ulhaq Z, Hoessli DC, Khogeer GS, Al-Sayed RR, Al-Aama JY. BRAF gene: from human cancers to developmental syndromes. Saudi J Biol Sci. 2015;22:359\u201373.","journal-title":"Saudi J Biol Sci"},{"key":"2689_CR41","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.18632\/oncotarget.716","volume":"3","author":"F Janku","year":"2012","unstructured":"Janku F, Wheler JJ, Naing A, Stepanek VM, Falchook GS, Fu S, Garrido-Laguna I, Tsimberidou AM, Piha-Paul SA, Moulder SL, Lee JJ, Luthra R, Hong DS, Kurzrock R. PIK3CA mutations in advanced cancers: characteristics and outcomes. Oncotarget. 2012;3:1566\u201375. https:\/\/doi.org\/10.18632\/oncotarget.716.","journal-title":"Oncotarget"},{"key":"2689_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00326","author":"F Molinari","year":"2014","unstructured":"Molinari F, Frattini M. Functions and regulation of the PTEN gene in colorectal cancer. Front Oncol. 2014. https:\/\/doi.org\/10.3389\/fonc.2013.00326.","journal-title":"Front Oncol"},{"key":"2689_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12885-020-07537-2","volume":"20","author":"A Arnold","year":"2020","unstructured":"Arnold A, Tronser M, Sers C, Ahadova A, Endris V, Mamlouk S, Horst D, M\u00f6bs M, Bischoff P, Kloor M, Bl\u00e4ker H. The majority of \u03b2-catenin mutations in colorectal cancer is homozygous. BMC Cancer. 2020;20:1038. https:\/\/doi.org\/10.1186\/s12885-020-07537-2.","journal-title":"BMC Cancer"},{"key":"2689_CR44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2017.08.037","volume":"86","author":"C Pr\u00e9vostel","year":"2017","unstructured":"Pr\u00e9vostel C, Blache P. The dose-dependent effect of SOX9 and its incidence in colorectal cancer. Eur J Cancer. 2017;86:150\u20137. https:\/\/doi.org\/10.1016\/j.ejca.2017.08.037.","journal-title":"Eur J Cancer"},{"key":"2689_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102735","volume":"299","author":"A-B Ramakrishnan","year":"2023","unstructured":"Ramakrishnan A-B, Burby PE, Adiga K, Cadigan KM. SOX9 and TCF transcription factors associate to mediate Wnt\/\u03b2-catenin target gene activation in colorectal cancer. J Biol Chem. 2023;299: 102735. https:\/\/doi.org\/10.1016\/j.jbc.2022.102735.","journal-title":"J Biol Chem"},{"key":"2689_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.7150\/ijms.4553","volume":"9","author":"YL Ding","year":"2012","unstructured":"Ding YL, Zhou Y, Xiang L, Ji ZP, Luo ZH. Expression of glioma-associated oncogene homolog 1 is associated with invasion and postoperative liver metastasis in colon cancer. Int J Med Sci. 2012;9:334\u20138. https:\/\/doi.org\/10.7150\/ijms.4553.","journal-title":"Int J Med Sci"},{"key":"2689_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-020-01178-9","volume":"124","author":"SV Vasaikar","year":"2021","unstructured":"Vasaikar SV, Deshmukh AP, den Hollander P, Addanki S, Kuburich NA, Kudaravalli S, Joseph R, Chang JT, Soundararajan R, Mani SA. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures. Br J Cancer. 2021;124:259\u201369. https:\/\/doi.org\/10.1038\/s41416-020-01178-9.","journal-title":"Br J Cancer"},{"key":"2689_CR48","volume-title":"venoms to drugs: venom as a source for the development of human therapeutics","author":"NC Henney","year":"2015","unstructured":"Henney NC, King GF. venoms to drugs: venom as a source for the development of human therapeutics. Springer; 2015."},{"key":"2689_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.toxicon.2014.10.020","volume":"92","author":"AL Harvey","year":"2014","unstructured":"Harvey AL. Toxins and drug discovery. Toxicon. 2014;92:193\u2013200.","journal-title":"Toxicon"},{"key":"2689_CR50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.toxicon.2010.10.008","volume":"57","author":"CA Hern\u00e1ndez-Aponte","year":"2011","unstructured":"Hern\u00e1ndez-Aponte CA, Silva-Sanchez J, Quintero-Hern\u00e1ndez V, Rodr\u00edguez-Romero A, Balderas C, Possani LD, Gurrola GB. Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus. Toxicon. 2011;57:84\u201392.","journal-title":"Toxicon"},{"key":"2689_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jbbm.2005.08.005","volume":"65","author":"RC Krieg","year":"2005","unstructured":"Krieg RC, Dong Y, Schwamborn K, Knuechel R. Protein quantification and its tolerance for different interfering reagents using the BCA-method with regard to 2D SDS PAGE. J Biochem Biophys Methods. 2005;65:13\u20139.","journal-title":"J Biochem Biophys Methods"},{"key":"2689_CR52","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1039\/C4MT00033A","volume":"6","author":"AB Nowakowski","year":"2014","unstructured":"Nowakowski AB, Wobig WJ, Petering DH. Native SDS-PAGE: high resolution electrophoretic separation of proteins with retention of native properties including bound metal ions. Metallomics. 2014;6:1068\u201378.","journal-title":"Metallomics"},{"key":"2689_CR53","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2174\/1871520621666210208105521","volume":"21","author":"IM Durmus","year":"2021","unstructured":"Durmus IM, Deveci I, Karakurt S. Synthesis of silica based nanoparticles against the proliferation of human prostate cancer. Anti-Cancer Agents Med Chem (Form Curr Med Chem-Anti-Cancer Agents). 2021;21:2553\u201362.","journal-title":"Anti-Cancer Agents Med Chem (Form Curr Med Chem-Anti-Cancer Agents)"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02689-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02689-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:58:29Z","timestamp":1746151109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02689-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02689-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"163"}}